#BEGIN_DRUGCARD DB07379

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C19H26ClN7O

# Chemical_IUPAC_Name:
(2S)-2-({6-[(3-amino-5-chlorophenyl)amino]-9-(propan-2-yl)-9H-purin-2-yl}amino)-3-methylbutan-1-ol

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:21:00 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL

# HET_ID:
AP9

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C19H26ClN7O/c1-10(2)15(8-28)24-19-25-17(23-14-6-12(20)5-13(21)7-14)16-18(26-19)27(9-22-16)11(3)4/h5-7,9-11,15,28H,8,21H2,1-4H3,(H2,23,24,25,26)/t15-/m1/s1

# InChI_Key:
InChIKey=RAMROQQYRRQPDL-OAHLLOKOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
7385

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
403.909

# Molecular_Weight_Mono:
403.188736196

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.11

# Predicted_LogS:
-3.7

# Predicted_Water_Solubility:
8.22e-02 g/l

# Primary_Accession_No:
DB07379

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6914609

# PubChem_Substance_ID:
99443850

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@](CO)(NC1=NC2=C(N=CN2C(C)C)C(NC2=CC(Cl)=CC(N)=C2)=N1)C(C)C

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:25:34 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CDK6

# Drug_Target_1_GenBank_ID_Gene:
X66365

# Drug_Target_1_GenBank_ID_Protein:
36623

# Drug_Target_1_GeneCard_ID:
CDK6

# Drug_Target_1_Gene_Name:
CDK6

# Drug_Target_1_Gene_Sequence:
>981 bp
ATGGAGAAGGACGGCCTGTGCCGCGCTGACCAGCAGTACGAATGCGTGGCGGAGATCGGG
GAGGGCGCCTATGGGAAGGTGTTCAAGGCCCGCGACTTGAAGAACGGAGGCCGTTTCGTG
GCGTTGAAGCGCGTGCGGGTGCAGACCGGCGAGGAGGGCATGCCGCTCTCCACCATCCGC
GAGGTGGCGGTGCTGAGGCACCTGGAGACCTTCGAGCACCCCAACGTGGTCAGGTTGTTT
GATGTGTGCACAGTGTCACGAACAGACAGAGAAACCAAACTAACTTTAGTGTTTGAACAT
GTCGATCAAGACTTGACCACTTACTTGGATAAAGTTCCAGAGCCTGGAGTGCCCACTGAA
ACCATAAAGGATATGATGTTTCAGCTTCTCCGAGGTCTGGACTTTCTTCATTCACACCGA
GTAGTGCATCGCGATCTAAAACCACAGAACATTCTGGTGACCAGCAGCGGACAAATAAAA
CTCGCTGACTTCGGCCTTGCCCGCATCTATAGTTTCCAGATGGCTCTAACCTCAGTGGTC
GTCACGCTGTGGTACAGAGCACCCGAAGTCTTGCTCCAGTCCAGCTACGCCACCCCCGTG
GATCTCTGGAGTGTTGGCTGCATATTTGCAGAAATGTTTCGTAGAAAGCCTCTTTTTCGT
GGAAGTTCAGATGTTGATCAACTAGGAAAAATCTTGGACGTGATTGGACTCCCAGGAGAA
GAAGACTGGCCTAGAGATGTTGCCCTTCCCAGGCAGGCTTTTCATTCAAAATCTGCCCAA
CCAATTGAGAAGTTTGTAACAGATATCGATGAACTAGGCAAAGACCTACTTCTGAAGTGT
TTGACATTTAACCCAGCCAAAAGAATATCTGCCTACAGTGCCCTGTCTCACCCATACTTC
CAGGACCTGGAAAGGTGCAAAGAAAACCTGGATTCCCACCTGCCGCCCAGCCAGAACACC
TCGGAGCTGAATACAGCCTGA

# Drug_Target_1_General_Function:
Not Available

# Drug_Target_1_General_References:
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
1639063	Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH: A family of human cdc2-related protein kinases. EMBO J. 1992 Aug;11(8):2909-17.
9751050	Russo AA, Tong L, Lee JO, Jeffrey PD, Pavletich NP: Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. 1998 Sep 17;395(6699):237-43.

# Drug_Target_1_HGNC_ID:
HGNC:1777

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3955

# Drug_Target_1_Locus:
7q21-q22

# Drug_Target_1_Molecular_Weight:
36939

# Drug_Target_1_Name:
Cell division protein kinase 6

# Drug_Target_1_Number_of_Residues:
326

# Drug_Target_1_PDB_ID:
1G3N

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00069	Pkinase

# Drug_Target_1_Protein_Sequence:
>Cell division protein kinase 6
MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR
EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTE
TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV
VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE
EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF
QDLERCKENLDSHLPPSQNTSELNTA

# Drug_Target_1_Reaction:
ATP + a protein = ADP + a phosphoprotein

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Probably involved in the control of the cell cycle. Interacts with D-type G1 cyclins

# Drug_Target_1_SwissProt_ID:
Q00534

# Drug_Target_1_SwissProt_Name:
CDK6_HUMAN

# Drug_Target_1_Synonyms:
EC 2.7.11.22
Serine/threonine- protein kinase PLSTIRE

# Drug_Target_1_Theoretical_pI:
6.43

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
S76368

# Drug_Target_2_GenBank_ID_Protein:
243355

# Drug_Target_2_GeneCard_ID:
72

# Drug_Target_2_Gene_Name:
72

# Drug_Target_2_Gene_Sequence:
>966 bp
ATGGAGGTCAAGCTGGACTTCAGTAGTGAAGACTTTAGCAACTATTCTTACAATTATAGT
GGAGACATATATTATGGAGATGTAGCGCCGTGTGTAGTGAACTTTTTAATTTCAGAGAGT
GCACTAGCATTCATATATGTGTTGATGTTTTTATGCAATGCAATTGGGAATTCTCTTGTA
CTGAGGACTTTTCTAAAGTATAGAGCTCAAGCTCAAAGTTTTGACTACTTGATGATGGGA
TTTTGTCTCAACAGCTTGTTCTTAGCTGGGTATCTGCTAATGAGACTTTTGCGCATGTTT
GAAATTTTTATGAATACTGAGCTGTGTAAGCTGGAAGCTTTTTTCTTAAATCTCAGCATT
TATTGGTCTCCTTTCATATTAGTTTTTATTAGTGTCTTGCGTTGTCTGCTAATATTTTGT
GCTACTAGACTGTGGGTGAAAAAGACTCTTATTGGGCAAGTATTTCTGTGCTGTTCATTT
GTATTAGCCTGCTTTGGAGCACTTCCTCATGTGATGGTGACATCATATTATGAACCATCT
TCTTGCATAGAGGAGGATGGTGTGTTGACTGAGCAGCTACGCACAAAGCTAAACACTTTT
CACACATGGTATAGCTTTGCAGGACCCCTCTTTATTACTGTAATATGCTATAGTATGTCA
TGTTATAAGTTATTCAAGACAAAGCTGTCTAAAAGAGCAGAGGTAGTCACGATAATTACA
ATGACAACACTGCTATTCATAGTGTTTTGTATACCATACTATATTATGGAAAGCATTGAT
ACTTTGTTGCGTGTTGGTGTAATAGAAGAGACATGTGCAAAGAGATCTGCTATAGTGTAT
GGAATTCAATGTACATATATGCTGTTGGTACTATATTATTGTATGTTACCTCTGATGTTT
GCTATGTTTGGAAGTCTCTTTAGGCAGCGCATGGCTGCATGGTGTAAAACTATTTGTCAC
TGTTAG

# Drug_Target_2_General_Function:
Involved in cell cycle

# Drug_Target_2_General_References:
10368294	Schulze-Gahmen U, Jung JU, Kim SH: Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6. Structure. 1999 Mar 15;7(3):245-54.
1309943	Nicholas J, Cameron KR, Honess RW: Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature. 1992 Jan 23;355(6358):362-5.
1314457	Nicholas J, Cameron KR, Coleman H, Newman C, Honess RW: Analysis of nucleotide sequence of the rightmost 43 kbp of herpesvirus saimiri (HVS) L-DNA: general conservation of genetic organization between HVS and Epstein-Barr virus. Virology. 1992 May;188(1):296-310.
1321287	Albrecht JC, Nicholas J, Biller D, Cameron KR, Biesinger B, Newman C, Wittmann S, Craxton MA, Coleman H, Fleckenstein B, et al.: Primary structure of the herpesvirus saimiri genome. J Virol. 1992 Aug;66(8):5047-58.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6340

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
28637.1

# Drug_Target_2_Name:
Cyclin homolog

# Drug_Target_2_Number_of_Residues:
254

# Drug_Target_2_PDB_ID:
1XO2

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00134	Cyclin_N
PF09241	Herp-Cyclin

# Drug_Target_2_Protein_Sequence:
>Cyclin homolog
MADSPNRLNRAKIDSTTMKDPRVLNNLKLRELLLPKFTSLWEIQTEVTVDNRTILLTWMH
LLCESFELDKSVFPLSVSILDRYLCKKQGTKKTLQKIGAACVLIGSKIRTVKPMTVSKLT
YLSCDCFTNLELINQEKDILEALKWDTEAVLATDFLIPLCNALKIPEDLWPQLYEAASTT
ICKALIQPNIALLSPGLICAGGLLTTIETDNTNCRPWTCYLEDLSSILNFSTNTVRTVKD
QVSEAFSLYDLEIL

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
May be highly relevant to the process of cellular transformation and rapid T-cell proliferation effected by HVS during latent infections of T-cells in susceptible hosts

# Drug_Target_2_SwissProt_ID:
Q01043

# Drug_Target_2_SwissProt_Name:
CGH2_SHV21

# Drug_Target_2_Synonyms:
V-cyclin

# Drug_Target_2_Theoretical_pI:
5.15

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB07379
